Nephron Recalls Asthmanefrin Inhalation Solution Due to Discoloration
Nephron Pharmaceuticals is voluntarily recalling Asthmanefrin inhalation solution starter kits due to discoloration. The recall covers 47,754 cartons distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II due to discoloration, a quality issue that may cause temporary or medically reversible adverse health consequences, fitting the Moderate severity criteria for low-risk contamination or labeling/quality errors without reported serious injury.
Plain-English summary
Nephron Pharmaceuticals Corp. is voluntarily recalling Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator, Starter Kit. The product consists of 10 individual foil-wrapped vials with 1 EZ Breathe Atomizer per carton. The recall was initiated because of discoloration in the product.
The recall affects 47,754 cartons of the medication, which were distributed nationwide. The specific lots involved are R4027A (expiration date 10/31/2015) and R4036A (expiration date 12/31/2015). The FDA has classified this recall as Class II, which indicates a situation where use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences.
Consumers who have this product should stop using it and contact their healthcare provider or the recalling firm for instructions on how to return or dispose of the medication. The recall was initiated by the firm on August 21, 2015, and was terminated on February 10, 2017.
The recalled product
- Product
- Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator, Starter Kit (Racepinephrine 11.25 mg) 10 individual foil wrapped vials with 1 EZ Breathe Atomizer per carton, Manufactured By: nephron pharmaceuticals corporation, Orlando, FL --- NDC 0487-2784-10
- Manufacturer
- Nephron Pharmaceuticals Corp.
- Category
- Drug — Inhalation Solution
- Hazard
- Affected units
- 47,754
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lots R4027A (Exp 10/31/2015)
- R4036A (Exp 12/31/2015)
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Nephron Pharmaceuticals Corp. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Nephron Pharmaceuticals Corp.
See all →- HighNephron Recalls Sodium Chloride Inhalation Solution Due to Sterility Concerns
FDA (Devices) · 2016-07-06
- HighNephron Recalls Sodium Chloride Inhalation Solution Due to Sterility Concerns
FDA (Devices) · 2016-07-06
- ModerateNephron Recalls Asthmanefrin Racepinephrine Inhalation Solution Due to Discoloration
FDA (Drugs) · 2015-12-09
- SevereNephron Recalls Ipratropium Bromide and Albuterol Sulfate Inhalation Solution
FDA (Drugs) · 2015-10-21
- SevereNephron Recalls Albuterol Sulfate Inhalation Solution Due to Sterility Concerns
FDA (Drugs) · 2013-10-30
Same hazard · discoloration
See all →- SevereShilpa Medicare Recalls Discolored Pemetrexed Injection Vials
FDA (Drugs) · 2026-08-26
- ModerateShilpa Medicare Recalls Discolored PEMRYDI RTU Injection Vials
FDA (Drugs) · 2026-08-26
- ModeratePantoprazole Sodium Tablets Recalled for Discoloration Issues
FDA (Drugs) · 2026-04-29
- ModerateTavaborole topical solution recalled from three lots because of discoloration
FDA (Drugs) · 2025-10-22
- ModerateAcetaminophen injection containers recalled after discoloration found in one lot
FDA (Drugs) · 2025-09-03